NCT05627895Completed
Brain Self-regulation for Parkinson's
A Feasibility Study of fMRI-neurofeedback in Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 15 Apr 2024
Brief summary (registry, in English)
To investigate feasibility of basal-ganglia regions as fMRI-neurofeedback targets in Parkinson's patients and evaluate self-regulation success
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 12 (actual)
- First submitted
- 16 Nov 2022
- Start date
- 17 Aug 2023
- Primary completion date
- 19 Feb 2024
- Lead sponsor
- Maastricht University
- Diseases
- Parkinson disease
- NCT number
- NCT05627895
What you commit to
- Study type: Observational
- Participants enrolled: 12
- From 17 Aug 2023 to the primary completion date, 19 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of illegal drugs (any in the last four weeks)
Other illness
- Exclusion criteria for MRI (e.g., cardiac pacemaker, certain metallic implants)
- History of psychotic disorder, bipolar disorder, or psychotic depression
- Advanced cognitive impairment (MoCA \<24) or dementia
Other
- Current excessive alcohol consumption that interferes with daily functioning
Who the study is looking for
- Diagnosis of Parkinson's disease (see 4.1) according to Movement Disorder Society (MDS) clinical diagnostic criteria (Postuma et al., 2015).
- Disease stage 1-3 according to the Hoehn and Yahr Scale
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Maastricht University Coordinator of this site? Confirm its status | Maastricht | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.